Author

Wenyue Sun

National Cancer InstituteORCID 0000-0003-1673-0895Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Genetic & Genomic Medicine· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:bulk RNA-seq· 3 Research Focus:cell type annotation· 3 Research Focus:differential expression· 3 Approach:experimental assay· 3 Research Focus:gene regulatory network inference· 3 Approach:statistical model· 2 Research Focus:clustering· 1

Frequent Co-Authors

Frederic G. BarriD· 4 shared Bishwanath ChatterjeeiD· 3 shared Benjamin Z. StantoniD· 2 shared Jack F. SherniD· 2 shared Jorge Lopez-Nava· 2 shared Rachel A. HoffmaniD· 2 shared Amy Yu· 1 shared Angela KimiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

Frederic G. BarrORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintOct 22, 2026

DNA methylation profiling reveals novel rhabdomyosarcoma subsets with distinct histologic, genetic and clinical properties

Wenyue Sun, Jorge Lopez-Nava, Jack F. Shern…·Frederic G. Barr

The paper uses DNA methylation profiling to identify distinct subsets within rhabdomyosarcoma subtypes, revealing clinical and genetic differences among them.

DOI 10.64898/2026.10.22.26365442

humanDNA methylation

𝕏 PostBluesky

Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewedApr 22, 2026

NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibition

Angela Kim, Prateek Bhardwaj, Collin D. Heer…·Juan C. Vasquez

This study evaluates NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitor therapy.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 2, 2025

Role of Myc family proteins in transcriptional regulation of growth and oncogenic transformation in fusion-positive rhabdomyosarcoma

Bishwanath Chatterjee, Pawan Kumar Raut, Hana Kim…·Frederic G. Barr

This study investigates the role of Myc family proteins in FP-RMS, showing MYCN or MYC dominance in some cases and functional redundancy in others, with both contributing to oncogenic properties.

DOI 10.64898/2025.12.01.690506

humanbulk RNA-seq

𝕏 PostBluesky

GenomicsbioRxivPreprintMay 16, 2025

Fusion transcription factor dosage controls cell state in rhabdomyosarcoma

Rachel A. Hoffman, Meng Wang, Benjamin D. Sunkel…·Benjamin Z. Stanton

This study shows that varying levels of PAX3::FOXO1 protein affect cell state and epigenetic heterogeneity in rhabdomyosarcoma.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky